Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   1.18  Index Moved Down -0.07%
PCP RS VMI ATI Munis Money Funds Small Growth Beers 
United States GSPC USD ...  |  Investing Themes


Processing
Collecting data for 096770 and CYNAF ...

Asset Comparison and Correlation

 View All Portfolios 
    
Investment horizon: 
  30 Days    Login   to change
Run Correlation
 
 SK Innovation  vs   PSUS THERAPEUTIC
 Compare Fundamentals  
Daily Returns (%)
CYNAF   096770   
 
Change Benchmark   
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
Timeline
Assuming 30 trading days horizon, SK Innovation is expected to generate 0.29 times more return on investment than CYNAF. However, SK Innovation is 3.45 times less risky than CYNAF. It trades about 0.21 of its potential returns per unit of risk. CYNAF is currently generating about -0.32 per unit of risk. If you would invest  14,200,000  in SK Innovation on April 21, 2013 and sell it today you would earn a total of  1,200,000  from holding SK Innovation or generate 8.45% return on investment over 30 days.

Diversification

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding SK Innovation and PSUS THERAPEUTIC in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.04
Parameters
Time Period1 Month [change]
DirectionPositive CYNAF.PK Moved Up vs 096770.KS
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns
Follow Correlation between 096770 and CYNAF with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add Correlation between 096770 and CYNAF to your reader
Syndicate
 
Share Correlation between 096770 and CYNAF 
Find Opportunities
 
Predicted Return Density
 
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
Returns   
CYNAF   096770   

SK Innovation

Alpha
 
Profile
    
SK Innovati
Performance
11
Out Of
100
Over 30
Days
?
89% of all equities and portfolios perform better than SK Innovation. Compared with the overall equity markets, risk-adjusted returns on investments in SK Innovation are ranked lower than 11 (%) of all global equities and portfolios over the last 30 days.
Check Performance
Backtest
Predict Price
    

Match ups for SK Innovati

HyundaiMtr vs. SK Innovation
HyundaiMtr2PB vs. SK Innovation
Hyundai Motor Co vs. SK Innovation
Mobis vs. SK Innovation
LGCHEM vs. SK Innovation
HynixSemi vs. SK Innovation
Samsung Life Insurance Co Ltd vs. SK Innovation
KEPCO vs. SK Innovation
KiaMtr vs. SK Innovation
Shinhan Financial Group Company Limited vs. SK Innovation
  

CYNAF

Alpha
 
Profile
    
CYNAF
Performance
0
Out Of
100
Over 30
Days
?
Over the last 30 days CYNAF has generated negative risk-adjusted returns adding no value to investors with long positions.
Check Performance
Backtest
Predict Price
    

Match ups for CYNAF

Federal National Mortgage Association vs. CYNAF
Federal National Mortgage Association vs. CYNAF
SK Innovation vs. CYNAF
KDDI Corp vs. CYNAF
Japan Tobacco Inc vs. CYNAF
Inpex Corporation vs. CYNAF
AP M vs. CYNAF
AP M vs. CYNAF
Citigroup Inc vs. CYNAF
Akbank TAS vs. CYNAF


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium